Biorce

Biorce is a biotechnology research company that provides an AI-powered clinical trial acceleration platform designed to help pharmaceutical, biotech, and contract research organization teams design and execute clinical studies with greater speed, efficiency, and regulatory-readiness. Its core platform uses artificial intelligence trained on extensive clinical trial data to support protocol creation, feasibility assessment, site selection, and alignment with regulatory expectations, helping streamline activities that traditionally slow early-phase and late-phase trial setup. Biorce’s tools generate explainable, documented outputs that teams can use to justify design decisions to regulatory bodies and reduce costly amendments that delay trials and increase operational effort. The company works with clinical operations and research leadership to integrate its technology into planning and execution workflows, aiming to shorten timelines and improve study predictability while maintaining scientific rigor and compliance. Biorce also engages in ongoing platform development to expand analytical capabilities and extend its utility across varied therapeutic areas.

Domain

biorce.com

Country

Spain

Industry

Artificial Intelligence (AI)

Employees

11-50

Last Funding

$52.0M

Founded

2023